Int. J. Dev. Biol. In Press
doi: 10.1387/ijdb.210087yl
© UPV/EHU Press

A screen of kinase inhibitors reveals a potential role of Chk1 in regulating Hydra head regeneration and maintenance

Yunjin Lee, Varun Muddaluru, Shiraz Anwar, Joanna Yvonne Wilson and Ana Regina Campos

Department of Biology, McMaster University, Hamilton, Ontario, Canada

ABSTRACT The cnidarian Hydra possesses remarkable regenerative capabilities which allows it to regrow lost or damaged body parts in a matter of days. Given that many key regulators of regeneration and development are evolutionarily conserved, Hydra is a valuable model system for studying the fundamental molecular mechanisms underlying these processes. In the past, kinase inhibitors have been useful tools for determining the role of conserved signaling pathways in Hydra regeneration and patterning. Here, we present a systematic screen of a commercially available panel of kinase inhibitors for their effects on Hydra regeneration. Isolated Hydra gastric segments were exposed to 5 µM of each kinase inhibitor and regeneration of the head and foot regions were scored over a period of 96 hours. Of the 80 kinase inhibitors tested, 28 compounds resulted in abnormal regeneration. We directed our focus to the checkpoint kinase 1 (Chk1) inhibitor, SB 218078, considering the role of Chk1 in G2 checkpoint regulation and the importance of G2-paused cells in Hydra regeneration. We found that Hydra exposed to SB 218078 were unable to regenerate the head and maintain head-specific structures. Furthermore, SB 218078-treated Hydra displayed a reduction in the relative proportion of epithelial cells, however no differences were seen for interstitial stem cells or their derivatives. Lastly, exposure to SB 218078 appeared to have no impact on the level of mitosis or apoptosis. Overall, our study demonstrates the feasibility of kinase inhibitor screens for studying Hydra regeneration processes and highlights the possible role for Hydra Chk1 in head regeneration and maintenance.

Keywords:

Hydra, regeneration, kinase inhibitors, small molecule screen, Chk1

*Corresponding author e-mail: camposa@mcmaster.ca